Beamion LUNG 1
Beamion LUNG-1 Phase Ia/Ib Study: Updated Results of HER2 TKI Zongertinib in Patients With Advanced NSCLC or Other Solid Tumors With HER2 Aberrations

Released: June 06, 2024

Expiration: June 05, 2025

Activity

Progress
1
Course Completed